Literature DB >> 28710987

The long-term quality of life in patients with persistent inflammation-immunosuppression and catabolism syndrome after severe acute pancreatitis: A retrospective cohort study.

Na Yang1, Baiqiang Li1, Bo Ye1, Lu Ke1, Faxi Chen1, Guotao Lu1, Fangfang Jiang1, Zhihui Tong1, Jieshou Li1, Weiqin Li2.   

Abstract

PURPOSE: To explore clinical characteristics and long-term quality of life (QOL) in severe acute pancreatitis (SAP) patients with persistent inflammation-immunosuppression and catabolism syndrome (PICS).
MATERIALS AND METHODS: SAP patients admitted to ICU were eligible for the retrospective cohort study if they needed prolonged intensive care (>14days). Post-ICU QOL was assessed by a questionnaire, including 36-item Short Form Health Survey (SF-36) and record of re-work in a long-term follow-up.
RESULTS: 214 SAP patients were enrolled, in which 149 (69.6%) patients met the criteria of PICS. PICS patients had more complications and ICU days compared to non-PICS patients (P<0.001), and their post-ICU mortality was higher (P=0.046). When adjusted for confounders, PICS was independently associated with higher post-ICU mortality (hazard ratio 4.5; 95% CI, 1.2 to 16.3; P=0.024). The 36-item Short Form Health Survey (SF-36) score was lower for PICS group in six subscales (P<0.001). Only 28.8% patients in the PICS group returned to work compared to 60% patients in the non-PICS group (P=0.001)
CONCLUSIONS: SAP patients with prolonged ICU stay had a high morbidity of PICS, which was a risk factor for the post-ICU mortality and poor long-term QOL.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic critical illness; Clinical outcomes; Long-term quality of life; Persistent inflammation-immunosuppression and catabolism syndrome; Severe acute pancreatitis

Mesh:

Year:  2017        PMID: 28710987     DOI: 10.1016/j.jcrc.2017.07.013

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  8 in total

Review 1.  Persistent inflammation, immunosuppression, and catabolism and the development of chronic critical illness after surgery.

Authors:  Philip A Efron; Alicia M Mohr; Azra Bihorac; Hiroyuki Horiguchi; McKenzie K Hollen; Mark S Segal; Henry V Baker; Christiaan Leeuwenburgh; Lyle L Moldawer; Frederick A Moore; Scott C Brakenridge
Journal:  Surgery       Date:  2018-05-26       Impact factor: 3.982

2.  C-reactive protein clustering to clarify persistent inflammation, immunosuppression and catabolism syndrome.

Authors:  Kensuke Nakamura; Kentaro Ogura; Hidehiko Nakano; Hiromu Naraba; Yuji Takahashi; Tomohiro Sonoo; Hideki Hashimoto; Naoto Morimura
Journal:  Intensive Care Med       Date:  2020-01-09       Impact factor: 17.440

3.  Dynamic Monitoring of Immunoinflammatory Response Identifies Immunoswitching Characteristics of Severe Acute Pancreatitis in Rats.

Authors:  Qian Zhuang; Liqiang Huang; Yue Zeng; Xu Wu; Gan Qiao; Minghua Liu; Lulu Wang; Yejiang Zhou; Yuxia Xiong
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

4.  Infectious Complications of Acute Pancreatitis Is Associated with Peripheral Blood Phagocyte Functional Exhaustion.

Authors:  Yaroslav M Susak; Olexandr O Dirda; Olexandr G Fedorchuk; Olekcandr A Tkachenko; Larysa M Skivka
Journal:  Dig Dis Sci       Date:  2020-03-13       Impact factor: 3.199

Review 5.  Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy.

Authors:  Hiroyuki Horiguchi; Tyler J Loftus; Russell B Hawkins; Steven L Raymond; Julie A Stortz; McKenzie K Hollen; Brett P Weiss; Elizabeth S Miller; Azra Bihorac; Shawn D Larson; Alicia M Mohr; Scott C Brakenridge; Hironori Tsujimoto; Hideki Ueno; Frederick A Moore; Lyle L Moldawer; Philip A Efron
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

6.  An Established Early Rehabilitation Therapy Demonstrating Higher Efficacy and Safety for Care of Intensive Care Unit Patients.

Authors:  Yatao Pang; Hongling Li; Long Zhao; Chunxia Zhang
Journal:  Med Sci Monit       Date:  2019-09-20

7.  Early Prediction for Persistent Inflammation-Immunosuppression Catabolism Syndrome in Surgical Sepsis Patients.

Authors:  Ming Zhong; Tingting Pan; Na-Na Sun; Ruo-Ming Tan; Wen Xu; Yu-Zhen Qiu; Jia-Lin Liu; Er-Zhen Chen; Hong-Ping Qu
Journal:  Int J Gen Med       Date:  2021-09-09

8.  Clinical Criteria for Persistent Inflammation, Immunosuppression, and Catabolism Syndrome: An Exploratory Analysis of Optimal Cut-Off Values for Biomarkers.

Authors:  Kensuke Nakamura; Kentaro Ogura; Hiroyuki Ohbe; Tadahiro Goto
Journal:  J Clin Med       Date:  2022-09-29       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.